ISPOR - PMH20 PSYCHOTROPIC MEDICATION USE AMONG CHILDREN WITH AUTISM SPECTRUM DISORDER- A COMPARISON BETWEEN MEDICAID AND COMMERCIAL INSURANCE

Full Text

PMH20 PSYCHOTROPIC MEDICATION USE AMONG CHILDREN WITH AUTISM SPECTRUM DISORDER- A COMPARISON BETWEEN MEDICAID AND COMMERCIAL INSURANCE

Abstract

Authors

L. Wang D. Leslie

Back to Volume 14, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now